Literature DB >> 2036750

Covariance analysis of laboratory variance in steady-state serum phenytoin concentrations.

H Costeff1, Z Groswasser, N Soroker, G van Belle.   

Abstract

Inpatients (n = 57) on long term prophylaxis with 2 oral phenytoin preparations were followed up via monthly checks of serum drug concentrations. Duplicate serum aliquots were submitted to 2 laboratories, and covariance analysis was used to estimate laboratory error. The laboratory-associated variance of examinations using the 'EMIT' or 'TDX' systems was 7.1 to 10 (mg/L)2, while that of chromatographic assays was 37.1 (mg/L)2. Laboratory errors were distributed in a non-normal fashion. The ratio of the maximum rate of metabolism (Vmax) and the Michaelis-Menten constant (Km) tended to remain constant between individuals. A linear analytical model showed little more residual variance than one based on Michaelis-Menten pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036750     DOI: 10.2165/00003088-199120040-00007

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  14 in total

1.  Who should test the testers?

Authors:  D N Baron
Journal:  JAMA       Date:  1987-02-27       Impact factor: 56.272

2.  An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interaction.

Authors:  T H Grasela; E J Antal; L Ereshefsky; B G Wells; R L Evans; R B Smith
Journal:  Clin Pharmacol Ther       Date:  1987-10       Impact factor: 6.875

3.  Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

4.  Coefficient of variation as measure of compliance.

Authors:  I E Leppik; J Cloyd; R J Sawchuk
Journal:  Lancet       Date:  1978-10-14       Impact factor: 79.321

5.  Comparison of assay methods used to measure antiepileptic drugs in plasma.

Authors:  J F Wilson; R W Marshall; J Williams; A Richens
Journal:  Ther Drug Monit       Date:  1983       Impact factor: 3.681

6.  Quality control in antiepileptic drug monitoring in Italy.

Authors:  M Bonati; D Castelli; N Leone; E Perucca; G Tognoni
Journal:  Drug Intell Clin Pharm       Date:  1985-12

7.  Phenytoin: the pseudosteady-state phenomenon.

Authors:  W H Theodore; Z P Qu; J Y Tsay; W Pitlick; R J Porter
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

8.  Bioavailability of phenytoin: comparison between three preparations.

Authors:  R Kitzes; Z Ackerman; M Levy; I Frumerman; A Shved; M Garty
Journal:  Isr J Med Sci       Date:  1985-04

9.  The 1978 College of American Pathologists Therapeutic Drug Monitoring Interlaboratory Survey Program.

Authors:  R Juel
Journal:  Am J Clin Pathol       Date:  1979-08       Impact factor: 2.493

10.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.